UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES AND EXCHANGE ACT OF 1934
        -------------------------------------------------------------------
       For the Quarter Ended January 31, 2002, Commission File Number 0-32887



                                  MYOCASH, INC.
              -----------------------------------------------------
             (Exact name of Registrant as specified in its charter)


                           Nevada              n/a
        ---------------------------  ----------------------------------
       (State of Incorporation) (I.R.S. Employer Indentification Number)


                  14 Pico Crescent, Thornhill, Ontario L4J 8P4
              ------------------------------------------------------
               (address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (905) 731-0189


                                 Not Applicable
       -------------------------------------------------------------------
       (Former name, address, or fiscal year if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the Registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                           Yes         x                No
                                  ------------        ------------
The total number of shares outstanding of the issuer's common shares, par value
$ .001 as of the date of this report, follow:

                             5,000,000


<PAGE>






PART I - FINANCIAL INFORMATION

Item 1.           Financial Statements








<PAGE>


MYOCASH, INC.
UNAUDITED INTERIM BALANCE SHEET
AS AT January 31, 2002

<TABLE>
<CAPTION>

                                                     January 31,  October 31,
                                                        2002         2001


ASSETS

Current Assets
<S>                                                 <C>               <C>
Cash ...............................................$    --           $   --

                                                     --------          ---------

Total Current Assets ..............................      --               --
                                                     --------          ---------

OTHER -  AT COST
Goodwill ..............................................  --                --
Incorporation costs ...................................  --                --
                                                     --------          ---------

Total Other Assets                                       --                --
                                                     --------          ---------


TOTAL ASSETS                                        $    --            $    --
                                                     ========          =========

</Table>

The accompanying notes are an integral part of these financial statements.

<Page>

MYOCASH, INC.
UNAUDITED INTERIM BALANCE SHEET
AS AT January 31, 2002
<TABLE>
<CAPTION>

                                                   January 31,  October 31,
                                                        2002         2001

LIABILITIES
<S>                                                <C>               <C>
Accounts payable ...................................$    --          $    --

LONG-TERM
Due to shareholders                                      --               --
                                                     --------          ---------


Total Liabilities ..................................     --               --
                                                     --------          ---------

STOCKHOLDERS' EQUITY

Preferred stock, authorized 5,000,000 shares par value
$ .001, none outstanding
Common stock, authorized 50,000,000 shares, par value
$ .001 - issued and outstanding                        5,000              5,000

Additional paid-in capital ..                            --                --
Deficit, accumulated during the development stage     (5,000)            (5,000)
                                                     -------           ---------
                                                         --                --
                                                     -------           ---------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY          $    --          $     --
                                                     =======           =========

</Table>


The accompanying notes are an integral part of these financial statements.
<Page>



MYOCASH, INC.
INTERIM UNAUDITED STATEMENT OF OPERATIONS
For the Three Months Ended January 31, 2002

<TABLE>
<CAPTION>

                                                                   FROM
                                                       THREE    INCEPTION
                                                      MONTHS   (Nov 17, 2000)
                                                       ENDED      TO
                                                      JANUARY 31, JANUARY 31,
                                                        2002       2002
<S>                                                <C>          <C>


REVENUE ..........................................  $    --    $    --
                                                     --------   --------


OPERATING EXPENSES
Professional fees                                        --         --
Amortization expenses
General and administrative                               --        5,000
                                                     --------   --------

Total Operating Expenses                                 --        5,000
                                                     --------   --------


NET LOSS FROM OPERATIONS                            $    --    $  (5,000)
                                                     ========   ========

Weighted Average Number of
  Common Shares Outstanding                          5,000,000
                                                     =========

</TABLE>

The accompanying notes are an integral part of these financial statements.
<PAGE>


MYOCASH, INC.
INTERIM UNAUDITED STATEMENT OF CASH FLOWS
From Inception(November 17, 2000) to January 31, 2002
<TABLE>
<CAPTION>


                                                                   FROM
                                                         THREE   INCEPTION
                                                        MONTHS (Nov 17, 2000)
                                                         ENDED      TO
                                                      JANUARY 31, JANUARY 31,
                                                        2002       2002

<S>                                                     <C>           <C>

Cash Flows From Operating Activities
Net income(loss) for the period .................... $    --      $  (5,000)
                                                      --------     --------

Adjustments to reconcile net loss to net cash
  in operating activities:
      Stock issued for services         ..........         --         4,455
      Stock issued for reimbursement
       of incorporation costs                                           545
   Changes in assets and liabilities
      Accounts receivable .............................    --           --
      Accounts payable ................................    --           --
                                                      --------      -------
                                                           --         5,000
                                                      --------      -------

Net Cash Provided By(Used in) Operating Activities         --           --
                                                      --------      -------

Cash Flows From Investing Activities
Purchase of goodwill ..................................    --           --
Incorporation costs ...................................    --           --
                                                      --------      -------

Net Cash Used in Investing Activities .................    --           --
                                                      --------      -------

Cash Flow From Financing Activities
Advances from shareholders ............................    --           --
Issuance of common stock ..............................    --           --
                                                      --------      -------
                                                           --           --
                                                      --------      -------


Increase(decrease) in Cash .........................       --           --

Cash and Cash Equivalents - Beginning of period .          --           --
                                                      --------      -------

Cash and Cash Equivalents - End of period .........  $     --      $    --
                                                      ========      =======

Supplementary Information
  Interest paid ................................ .   $     --      $    --
                                                      ========      =======
  Taxes paid .....................................   $     --      $    --
                                                      ========      =======
</TABLE>

The accompanying notes are an integral part of these financial statements.
<PAGE>



MYOCASH, INC.
INTERIM UNAUDITED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
From Inception(November 17, 2000) to January 31, 2002
<TABLE>
<CAPTION>


                                                        Deficit
                                                     Accumulated
                                        Additional    During the
                       Common Stock      Paid-In     Development
                     Shares   Amount     Capital       Stage        Totals
              ---------------------------------------------------------------
<S>                <C>         <C>      <C>        <C>            <C>

Balance - November
  17, 2000             --      $   --    $    --    $     --       $    --

Stock issued for
  services          4,455,000    4,455        --          --           4,455

Stock issued for
 incorporation costs  545,000      545        --          --             545


Net loss for period                                     (5,000)       (5,000)
                    ---------  -------    ---------   --------      --------

BALANCE - October 31,
     2001           5,000,000    5,000        --        (5,000)         --

Net loss for
    period             --         --          --          --            --
                   ----------  -------    ---------   --------      --------

Balance - January
   31, 2002         5,000,000 $  5,000   $    --     $  (5,000)    $    --
                   ==========  =======    ========    ========      ========



</TABLE>


The accompanying notes are an integral part of these financial statements.









                                                                       .........



<PAGE>


                                 MYOCASH, INC.
                          (A Development Stage Company)
                 Notes To Unaudited Interim Financial Statements
                                  January 31, 2002

Note 1 - Organization and Summary of Significant Accounting Policies:

     Nature of Business

          MYOCASH,  INC., Inc. (the "Company") was  incorporated on November 17,
     2000 under the laws of the State of Nevada.  The Company's primary business
     operations  are to and  engage in the  acquisition  of a  technology  based
     company.  The Company is searching  for a viable entity upon which to merge
     and/or  acquire.  The Company intends on going public in order to raise the
     funds required in order to fulfill its business objectives.

     The Company's fiscal year end is October 31,

     Basis of  Presentation

     Development  Stage  Company

          The  Company  has  not  earned  any  revenue  from  limited  principal
     operations.  Accordingly,  the Company's activities have been accounted for
     as those of a  Development  Stage  Enterprise'  as set  forth in  Financial
     Accounting   Standards   Board  Statement  No.  7  ("SFAS  7").  Among  the
     disclosures  required by SFAS 7 are that the Company's financial statements
     be  identified  as  those  of a  development  stage  company,  and that the
     statements of  operations,  stockholders"  equity  (deficit) and cash flows
     disclose activity since the date of the Company's inception.

     Basis of Accounting

          The  accompanying  financial  statements  have  been  prepared  on the
     accrual  basis  of  accounting  in  accordance   with  generally   accepted
     accounting principles.

     Estimates

          The  preparation of financial  statements in conformity with generally
     accepted  accounting  principles  requires management to make estimates and
     assumptions   that  affect  certain   reported   amounts  and  disclosures.
     Accordingly, actual results could differ from those estimates.

     Cash and Cash Equivalents

          For purposes of the  statement of cash flows,  the Company  considered
     all cash and other highly  liquid  investments  with initial  maturities of
     three months or less to be cash equivalents.

<PAGE>

                                 MYOCASH, INC.
                         (A Development Stage Company)
                  Notes To Unaudited Interim Financial Statements
                                January 31, 2002


     Net earning (loss) per share

          Basic and diluted net loss per share  information  is presented  under
     the  requirements of SFAS No. 128,  Earnings per Share.  Basic net loss per
     share is computed by dividing  net loss by the weighted  average  number of
     shares of common stock  outstanding for the period,  less shares subject to
     repurchase.  Diluted net loss per share reflects the potential  dilution of
     securities  by adding  other  common  stock  equivalents,  including  stock
     options,  shares subject to repurchase,  warrants and convertible preferred
     stock, in the  weighted-average  number of common shares  outstanding for a
     period, if dilutive. All potentially dilutive securities have been excluded
     from the computation, as their effect is anti-dilutive.

     Income Taxes

          The  Company  accounts  for income  taxes  under SFAS No.  109,  which
     requires the asset and liability  approach to accounting  for income taxes.
     Under this method,  deferred tax assets and  liabilities are measured based
     on  differences  between  financial  reporting  and tax bases of assets and
     liabilities  measured using enacted tax rates and laws that are expected to
     be in effect when differences are expected to reverse.

Note 2 - Capital Stock Transactions

          The  authorized  capital  common stock is 50,000,000  shares of common
     stock at $.001 par value.  The Company has issued 5,000,000 of common stock
     of which 4,455,000 was for services rendered as administrative  expenses by
     the  founders at a cost of $4,455 and $ 545 for  incorporation  costs which
     were expensed during this interim period.

<PAGE>



                                  MYOCASH, INC.
                          (A Development Stage Company)
                     Notes To Unaudited Interim Financial Statements
                               January 31, 2002


Note 3 - Going Concern:

     The accompanying financial statements have been prepared in conformity with
generally accepted accounting principles, which contemplates continuation of the
Company as a going concern.  The Company operations are in the development stage
and the Company has  generated no income.  The future  success of the Company is
likely  dependent  on its  ability to attain  additional  capital to develop its
proposed  products and ultimately,  upon its ability to attain future profitable
operations.  There can be no assurance  that the Company will be  successful  in
obtaining  such  financing,  or that it will  attain  positive  cash  flow  from
operations.

Note 4 -Income Taxes

     There has been no provision  for U.S.  federal,  state,  or foreign  income
taxes for any period because the Company has incurred  losses in all periods and
for all jurisdictions.

     Deferred income taxes reflect the net tax effects of temporary  differences
between the carrying  amounts of assets and liabilities for financial  reporting
purposes and the amounts used for income tax purposes. Significant components of
deferred tax assets are as follows:

Deferred tax assets
  Net operating loss carryforwards                       $  5,000
  Valuation allowance for deferred tax assets              (5,000)
                                                          -------
Net deferred tax assets                                  $    -
                                                          =======

     Realization  of deferred tax assets is dependent upon future  earnings,  if
any, the timing and amount of which are uncertain. Accordingly, the net deferred
tax assets have been fully  offset by a valuation  allowance.  As of January 31,
2002, the Company had net operating loss  carryforwards of approximately $ 5,000
for federal and state income tax purposes. These carryforwards,  if not utilized
to  offset  taxable  income  begin to  expire  in 2017.  Utilization  of the net
operating  loss may be  subject  to  substantial  annual  limitation  due to the
ownership change  limitations  provided by the Internal Revenue Code and similar
state  provisions.  The annual  limitation could result in the expiration of the
net operating loss before utilization.







<PAGE>


Item 2:           Management's Discussion and Analysis or Plan Of Operation

Not applicable.

PART II - OTHER INFORMATION

Item 1:           Legal Proceedings

There are no legal proceedings applicable.

Item 2:           Changes in Securities and Use of Proceeds

Not Applicable

Item 3:           Defaults upon Senior Securities

Not Applicable.

Item 4:           Submission of Matters to a Vote of Security Holders

Not Applicable

Item 5:           OTHER INFORMATION

     The registrant has changed its head office to 14 Pico Crescent,  Thornhill,
     Ontario L4J 8P4 effective immediately.

Item 6:           Exhibits and Reports on Form 8-K

     Exhibit 11 -  Computation  of earnings per common share - see  Statement Of
Operations

Reports on Form 8-K - None

<PAGE>

                                   SIGNATURES

          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
          the  Registrant  has duly  caused  this  report  to be  signed  by the
          undersigned thereunto duly authorized.

          MYOCASH, INC.


BY:               /s/   Marvin Winick
         -------------------------------
         Marvin Winick, President

Dated:            December 10, 2002